Tonix Pharmaceuticals shares rise 1.01% premarket after AbbVie's acquisition of Capstan Therapeutics.

miércoles, 20 de agosto de 2025, 6:36 am ET1 min de lectura
TNXP--
Tonix Pharmaceuticals Holding Corp. rose 1.01% in premarket trading. The company's stock price movement is not directly related to the news events provided, which are all about AbbVie Inc. and its acquisition of Capstan Therapeutics.

Tonix Pharmaceuticals shares rise 1.01% premarket after AbbVie's acquisition of Capstan Therapeutics.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios